BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
38 hedge funds and large institutions have $10.5M invested in BRAINSTORM CELL THERAPUTC in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.79% → 0.78% (-0.01%)
94% less call options, than puts
Call options by funds: $62K | Put options by funds: $1.06M
Holders
38
Holding in Top 10
1
Calls
$62K
Puts
$1.06M
Top Buyers
| 1 | +$228K | |
| 2 | +$183K | |
| 3 | +$159K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$95.4K |
| 5 |
Renaissance Technologies
New York
|
+$87.7K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$9.05K | |
| 3 | -$7K | |
| 4 |
Bank of New York Mellon
New York
|
-$1.76K |
| 5 |
LPC
Loeb Partners Corp
New York
|
-$1.69K |